Patient Care Intervention Center

Blog

Private In-equity: Whose Interests Do We Serve?

Print Email
(0 votes)
lady justice

PCIC co-founder Dr. David Buck, in collaboration with Haaris Mateen, Assistant Professor of Finance at University of Houston Bauer College of Business, published an article in The Medical Care Blog breaking down the root causes of health inequity in the United States and suggesting a path forward for health and social care that supports vulnerable populations to not only survive, but thrive.

The pharmaceutical industry is a behemoth in the United States. In 2023, the 20 largest pharmaceutical companies had a market capitalization of $3.78 trillion dollars. Pharma companies spent more than $15 million dollars in contributions through political action commuttees during the 2020 election cycle. Analysts constantly see new avenues of generationg revenues and profits for the industry including, most recently, obesity drugs which are predicted to become a $44 billion market by 2030, according to Bloomberg Intelligence. Private equity has targeted elder and primary care for a quick investment return leaving long-term in-equities with significant public and health policy implications. Read Article
Last modified on Wednesday, 31 July 2024 15:33

Recent Posts

Our Mission

Humanize health equity by integrating clinical, behavioral, and social determinants of health into serviceable insights that our partners use to drive action, putting each individual on a path toward achievable health and well-being.

We Envision

Creating a new reality of integrated effective care that will transform the lives of all people, especially vulnerable populations – a beacon for True Health Equity.

Copyright © Healthcare for Special Populations. All rights reserved.
Team Site